CML – is difficult to monitor and manage using traditional solutions. New RNA-based assays are hitting the market to make ...

and chronic myeloid leukemia (CML). This innovative technology offers significant advantages over traditional diagnostic methods, especially in resource-limited settings. By providing timely and ...

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Scemblix was granted accelerated approval by the FDA for the treatment of certain patients newly diagnosed with chronic ...

Food security, healthcare, electricity, and employment are among the many fundamental human rights to which innovative technology is being applied—and making a difference. More than a billion ...

Gurmat Bhatia is well-known for proficient work in cloud-native software, machine learning, artificial intelligence, and real ...

Chase Mining Corporation Limited (AU:GCM) has released an update. Chase Mining Corporation Limited has acquired an innovative technology to ...

AutoStore believes its automated fulfillment solutions exemplify the type of innovative technology that Gartner emphasizes as essential for modern retail operations. “Our commitment to ...

The Food and Drug Administration (FDA) has granted accelerated approval to Scemblix ® (asciminib) for the treatment of adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid ...

Based on RNA technology, ICON’s new assay offers huge improvements on how CML is monitored ... NGS assay known as Dup-Seq BCR::ABL1. This innovative assay enables the identification of both ...